Sort
39,280 grants matching “leukemia”
Development of Gleevec for TB and TB/HIV
$599,999Daniel Kalman · Emory University · UH2 · FY2016 · AI
ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER
$599,999Elisabeth Paietta · Montefiore Medical Center (Bronx, Ny) · U10 · FY2017 · CA
ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER
$599,999Elisabeth Paietta · Montefiore Medical Center (Bronx, Ny) · U10 · FY2015 · CA
ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER
$599,999Elisabeth Paietta · Montefiore Medical Center (Bronx, Ny) · U10 · FY2018 · CA
ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER
$599,999Elisabeth Paietta · Montefiore Medical Center (Bronx, Ny) · U10 · FY2016 · CA
Squamous Cell Carcinoma of the Lung: Validation of Molecular Signatures for Progn
$599,973Fred R Hirsch · University Of Colorado Denver · U01 · FY2012 · CA
Combination Therapy in B-Chronic Lymphocytic Leukemia
$599,968Neil E Kay · Mayo Clinic Rochester · R01 · FY2009 · CA
An Academic-Industry Partnership to Advance Functional Genomics for Personalized Oncology.
$599,950Christopher J Kemp · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA
The Brooklyn Minority-Based Community Clinical Oncology Program
$599,843William Barney Solomon · Suny Downstate Medical Center · U10 · FY2012 · CA
ECOG-ACRIN Biorepositories to Support NCTN
$599,831Ignacio I. Wistuba · Ecog-Acrin Medical Research Foundation · U24 · FY2018 · CA
Targeting CDK6 expression/activity in Ph+ and Ph1-like acute lymphoblastic leukemia (ALL)
$599,770Bruno Calabretta · Thomas Jefferson University · R01 · FY2024 · CA
Retrovirus Biology
$599,749Alan Rein · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Structure, Function and Applications of Inteins
$599,719Tom W Muir · Princeton University · R01 · FY2022 · GM
PPM1D in Clonal Hematopoiesis and Malignancies
$599,632Margaret Goodell · Baylor College Of Medicine · R01 · FY2021 · CA
PPM1D in Clonal Hematopoiesis and Malignancies
$599,632Margaret Goodell · Baylor College Of Medicine · R01 · FY2020 · CA
Stem Cells, Differentiation and Therapeutic Resistance in AML
$599,584Martin Carroll · University Of Pennsylvania · R01 · FY2012 · CA
THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE
$599,536Mark A Watson · Washington University · U24 · FY2018 · CA
Control of GVHD by Probiotics with individual Commensal Bacteria
$599,503Xue-Zhong Yu · Medical College Of Wisconsin · R01 · FY2024 · HL
Ezh2-mediated Epigenetic Effects and Alloimmunity
$599,475Yi Zhang · Temple Univ Of The Commonwealth · R01 · FY2017 · HL
Exercise as an Immune Adjuvant for Gamma Delta T-cell Therapies in Hematologic Malignancies
$599,469Richard J Simpson · University Of Arizona · R01 · FY2024 · CA
North Shore CCOP
$599,459Vincent P Vinciguerra · Feinstein Institute For Medical Research · U10 · FY2011 · CA
Biomarkers for predicting response to Hsp90 therapy
$599,324Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Discovery of New Therapeutic Targets in ALL
$599,281Gary L. Gilliland · Dana-Farber Cancer Inst · P01 · FY2007 · CA
Tailoring CAR T cell therapy for Hodgkin Lymphoma
$599,281Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
$599,222Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA